Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Underwood

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
BMC Infectious Diseases|October 30, 2016
Defining cognitive impairment in people-living-with-HIV: the POPPY studyDavide De Francesco, Jonathan Underwood, Frank A Post, et al.
Open Forum Infectious Diseases|July 3, 2019
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive ImpairmentJonathan Underwood, Davide De Francesco, James H Cole, et al.
International Journal of STD & AIDS|December 5, 2019
Cognitive function and drivers of cognitive impairment in a European and a Korean cohort of people living with HIVDavide De Francesco, Jae-Phil Choi, Jun Y Choi, et al.
AIDS (London, England)|July 2, 2019
Risk factors and impact of patterns of co-occurring comorbidities in people living with HIVDavide De Francesco, Jonathan Underwood, Emmanouil Bagkeris, et al.
AIDS Care|December 28, 2020
Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individualsDavide De Francesco, Jonathan Underwood, Jane Anderson, et al.
International Journal of STD & AIDS|April 20, 2019
Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individualsDavide De Francesco, Alan Winston, Jonathan Underwood, et al.
Journal of Clinical Pathology|February 20, 2021
Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluationMark J Ponsford, Ross J Burton, Leitchan Smith, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Plos One|July 21, 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIVDavide De Francesco, Xinzhu Wang, Laura Dickinson, et al.
Open Forum Infectious Diseases|January 25, 2024
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/RitonavirLuke B Snell, Aimee McGreal-Bellone, Clemency Nye, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|October 30, 2016
Defining cognitive impairment in people-living-with-HIV: the POPPY studyDavide De Francesco, Jonathan Underwood, Frank A Post, et al.
Open Forum Infectious Diseases|July 3, 2019
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive ImpairmentJonathan Underwood, Davide De Francesco, James H Cole, et al.
International Journal of STD & AIDS|December 5, 2019
Cognitive function and drivers of cognitive impairment in a European and a Korean cohort of people living with HIVDavide De Francesco, Jae-Phil Choi, Jun Y Choi, et al.
AIDS (London, England)|July 2, 2019
Risk factors and impact of patterns of co-occurring comorbidities in people living with HIVDavide De Francesco, Jonathan Underwood, Emmanouil Bagkeris, et al.
AIDS Care|December 28, 2020
Correlation between computerised and standard cognitive testing in people with HIV and HIV-negative individualsDavide De Francesco, Jonathan Underwood, Jane Anderson, et al.
International Journal of STD & AIDS|April 20, 2019
Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individualsDavide De Francesco, Alan Winston, Jonathan Underwood, et al.
Journal of Clinical Pathology|February 20, 2021
Examining the utility of extended laboratory panel testing in the emergency department for risk stratification of patients with COVID-19: a single-centre retrospective service evaluationMark J Ponsford, Ross J Burton, Leitchan Smith, et al.
The Lancet. Respiratory Medicine|November 17, 2023
Efficacy and safety of baricitinib or ravulizumab in adult patients with severe COVID-19 (TACTIC-R): a randomised, parallel-arm, open-label, phase 4 trialFrances C Hall, Joseph Cheriyan, Andrew P Cope, et al.
Plos One|July 21, 2021
Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIVDavide De Francesco, Xinzhu Wang, Laura Dickinson, et al.
Open Forum Infectious Diseases|January 25, 2024
A Multinational Case Series Describing Successful Treatment of Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection Caused by Omicron Sublineages With Prolonged Courses of Nirmatrelvir/RitonavirLuke B Snell, Aimee McGreal-Bellone, Clemency Nye, et al.
Pageof 7